[Lab] CPC orfo — Janoshik came back 98.2% against a claimed 97.5%
Posting this because the title is the whole finding — CPC orfo — Janoshik came back 98.2% against a claimed 97.5% — and a number without its method is a rumour.
The relevant figures are 98.2% and 97.5%, and they come from the same log I have kept the whole time.
It is a non-peptide small-molecule agonist at the GLP-1 receptor. That is a substantial medicinal chemistry achievement: getting a small molecule to activate a receptor evolved for a peptide ligand.
Because it is not a peptide, it is not subject to the same degradation pathways, does not require the absorption enhancers used for oral peptides, and can be formulated as a conventional tablet.
Please do not ask me what dose you should be on. I genuinely do not know and neither does anyone else here.
- CPCPC source pageChinese Peptide Company Co., Ltd. · Hangzhou · 93% here, rank 12 · shop at chinesepeptidecompany.net →
nofollow and sponsored; nobody here is paid for it.best — the order this archive was captured in
Milligram comparisons across molecule classes are meaningless. Potency is a property of the molecule at its receptor, not of the number on the label.
Disagree. You are comparing doses across a small molecule and a peptide, which is not a comparison of anything.
phase 3 is where the comparison becomes fair
Compared milligram figures across two completely different molecule classes in a comment. Deserved the correction.